Antimicrobial resistance (AMR) is one of the greatest threats to human health that, by 2050,
will lead to more deaths from bacterial infections than cancer. New antimicrobial agents …

Escherichia coli remains one of the most frequent causes of several common bacterial
infections in humans and animals. E. coli is the prominent cause of enteritis, urinary tract …

Antibiotic resistance is increasing at a rate that far exceeds the pace of new development of
drugs. Antimicrobial peptides, both synthetic and from natural sources, have raised interest …

The escalation of multidrug-resistant pathogens has created a dire need to develop novel
ways of addressing this global therapeutic challenge. Because of their antimicrobial …

An important class of cytolytic antimicrobial peptides (AMPs) assumes an amphipathic, α-
helical conformation that permits efficient interaction with biological membranes. Host …

Dendrimers have attracted immense interest in science and technology due to their unique
chemical structure that offers a myriad of opportunities for researchers. Dendritic design …

Bacterial infections are raising serious concern across the globe. The effectiveness of
conventional antibiotics is decreasing due to global emergence of multi-drug-resistant …

Invasive fungal infections are associated with high mortality rates, despite appropriate
antifungal therapy. Limited therapeutic options, resistance development and the high …

The emergence and re-emergence of bacterial strains that are resistant to current antibiotics
reveal the clinical need for new agents that possess broad-spectrum antibacterial activity …

Poly (amidoamine)(PAMAM) dendrimer derivatives have been investigated for their
biological applications, especially for delivery of drugs, including antimicrobial drugs to …